Orthopediatrics (KIDS) Restructuring Costs (2024 - 2025)
Orthopediatrics' (KIDS) quarterly Restructuring Costs came in at $296000.0 in Q4 2025, down 91.9% year-on-year from $3.7 million in Q4 2024, and down 87.1% on a QoQ basis from $2.3 million in Q3 2025.
Orthopediatrics (KIDS) Restructuring Costs (2024 - 2025) Analysis & Trends
Orthopediatrics (KIDS) has 2 years of Restructuring Costs data on file, last reported at $296000.0 in Q4 2025.
- On a quarterly basis, Restructuring Costs fell 91.9% year-over-year to $296000.0 in Q4 2025; TTM through Mar 2026 was $5.6 million, a 50.58% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 53.33% from the prior year.
- Restructuring Costs for Q4 2025 stood at $296000.0, down from $2.3 million in the prior quarter.
- Over the last five years, Restructuring Costs for KIDS reached as high as $3.7 million in Q4 2024 and fell as low as $40000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 296,000.00 |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 40,000.00 |
| Dec 31, 2024 | 3.65 Mn |